Causes of Seizures on Day 3 of Life
Hypoxic-ischemic encephalopathy (HIE) is the most common cause of seizures on day 3 of life, accounting for approximately 23% of neonatal seizures, with the majority occurring within the first three days after birth 1, 2.
Primary Etiologies by Timing
Seizures on day 3 of life fall within the critical early neonatal window when specific pathologies predominate:
Most Common Causes (First 3 Days)
Hypoxic-Ischemic Encephalopathy (HIE): The leading cause, with significantly higher proportion of seizures in the first 72 hours compared to other etiologies 1. HIE-related seizures typically manifest within 12-48 hours but can present through day 3.
Intracranial Hemorrhage: Including intraventricular hemorrhage (IVH) and other bleeding patterns. High seizure burden on day 3 is specifically associated with high-grade IVH 3.
Stroke: Both arterial ischemic stroke and cerebral sinovenous thrombosis present in this timeframe 4.
Structural Brain Anomalies: Congenital malformations become apparent in early neonatal period 5.
Genetic/Metabolic Causes
Benign Familial Neonatal Epilepsy (BFNE): Classic presentation is seizures beginning at day 3 of life (hence the historical term "fifth-day fits"), caused by KCNQ2 or KCNQ3 channelopathies 4, 6. This is a critical diagnosis to consider specifically on day 3, as it requires sodium channel blocker therapy rather than standard phenobarbital.
Other Genetic Epilepsies: KCNQ2 mutations beyond BFNE can present with early-onset seizures 1.
Inborn Errors of Metabolism: Including pyridoxine-dependent epilepsy, which should be considered if seizures are refractory to standard antiseizure medications 4.
Infectious Causes
- Meningitis/Encephalitis: Bacterial or viral CNS infections can manifest by day 3, particularly with early-onset sepsis 5.
Other Causes
Drug Withdrawal: From maternal substance use (opioids, benzodiazepines) 5.
Electrolyte Disturbances: Hypoglycemia, hypocalcemia, hypomagnesemia, hyponatremia 5.
Critical Diagnostic Considerations for Day 3 Seizures
Family history is essential: If positive for neonatal seizures, strongly suspect BFNE/channelopathy, which fundamentally changes first-line treatment from phenobarbital to phenytoin or carbamazepine 4.
EEG patterns matter: Unusual electrical attenuation at seizure onset may indicate BFNE 6. The majority of neonatal seizures are electrographic-only (detectable only on EEG), making amplitude-integrated EEG or conventional EEG monitoring essential for accurate diagnosis 4, 7.
Seizure semiology: Subtle seizures are the predominant type (46% of cases), followed by focal clonic and focal tonic patterns 1, 5. Only focal clonic and focal tonic seizures can be diagnosed clinically without EEG confirmation 4.
Common Pitfalls
Missing BFNE: Day 3 is the classic presentation time for benign familial neonatal epilepsy. Failure to obtain family history leads to inappropriate phenobarbital use when sodium channel blockers are indicated 4.
Relying on clinical observation alone: Up to 85% of neonatal seizures may be purely electrographic without clinical manifestations, leading to undertreatment and increased seizure burden 7.
Delayed metabolic workup: If seizures are refractory to second-line therapy without identified etiology, pyridoxine trial should be attempted promptly 4.
Prognostic Implications
Etiology is the primary determinant of long-term outcome, not seizure burden alone 7. However, high seizure burden on day 3 is associated with increased risk of white matter injury and death 3. Early language development may be impaired even after controlling for social risk factors 3.